The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Upregulation of insulin receptor substrate-2 in pancreatic β cells prevents diabetes
Open accessAbstract
The insulin receptor substrate-2 (Irs2) branch of the insulin/IGF signaling system coordinates peripheral insulin action and pancreatic beta cell function, so mice lacking Irs2 display similarities to humans with type 2 diabetes. Here we show that beta cell-specific expression of Irs2 at a low or a high level delivered a graded physiologic response that promoted beta cell growth, survival, and insulin secretion that prevented diabetes in Irs2-/- mice, obese mice, and streptozotocin-treated mice; and that upon transplantation, the transgenic islets cured diabetes more effectively than WT islets. Thus, pharmacological approaches that promote Irs2 expression in beta cells, especially specific cAMP agonists, could be rational treatments for beta cell failure and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
Insulin-promoter-factor 1 is required for pancreas development in mice
Jonsson, J., Carlsson, L., Edlund, T., & Edlund, H. (1994) · Nature · doi:10.1038/371606a0 · Cited by 1,785
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Self-citationZander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Ten years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177
Kulkarni, R. N., Brüning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80546-2 · Cited by 1,148
Self-citationStoffers, D. A., Zinkin, N. T., Stanojevic, V., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng0197-106 · Cited by 1,106
IRS proteins and the common path to diabetes
White, M. F. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2001 · Cited by 925
Self-citationAhlgren, U., Jonsson, J., Jonsson, L., Simu, K., & Edlund, H. (1998) · Genes & Development · doi:10.1101/gad.12.12.1763 · Cited by 918
Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16885 · Cited by 726
Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589
Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W., Wright, C. V. E., White, M. F., Arden, K. C., & Accili, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16857 · Cited by 580
Self-citationPick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551
cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M., & Montminy, M. (2003) · Genes & Development · doi:10.1101/gad.1097103 · Cited by 543
Self-citationIrs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling
Withers, D. J., Burks, D. J., Towery, H. H., Altamuro, S. L., Flint, C. L., & White, M. F. (1999) · Nature Genetics · doi:10.1038/12631 · Cited by 529
Self-citationClark, A., Wells, C. A., BULEY, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J. S., Holman, R. R., & Turner, R. C. (1988) · PubMed · Cited by 518
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502
Tran, H., Brunet, A., Griffith, E. C., & Greenberg, M. E. (2003) · Science's STKE · doi:10.1126/stke.2003.172.re5 · Cited by 434
Kulkarni, R. N., Holzenberger, M., Shih, D. Q., Ozcan, U., Stoffel, M., Magnuson, M. A., & Kahn, C. R. (2002) · Nature Genetics · doi:10.1038/ng872 · Cited by 363
Self-citationTranscriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor
Waeber, G. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1327 · Cited by 348
Increased islet apoptosis in Pdx1+/– mice
Johnson, J. D., Ahmed, N. T., Luciani, D. S., Han, Z., Tran, H., Fujita, J., Misler, S., Edlund, H., & Polonsky, K. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16537 · Cited by 342
Islet growth and development in the adult
Bonner-Weir, S. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0240297 · Cited by 331
Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A., & Nerup, J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4077 · Cited by 304
Previs, S. F., Withers, D. J., Ren, J.-M., White, M. F., & Shulman, G. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006490200 · Cited by 291
Self-citationInsulin Resistance or Insulin Deficiency: Which Is the Primary Cause of NIDDM?
Taylor, S. I., Accili, D., & Imai, Y. (1994) · Diabetes · doi:10.2337/diab.43.6.735 · Cited by 289
The IRS‐signalling system during insulin and cytokine action
Yenush, L., & White, M. F. (1997) · BioEssays · doi:10.1002/bies.950190608 · Cited by 272
Self-citationInsulin Receptor Knockout Mice
Kitamura, T., Kahn, C. R., & Accili, D. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142540 · Cited by 260
ISOLATION OF RAT PANCREATIC ISLETS BY DUCTAL INJECTION OF COLLAGENASE1
SUTTON, R., PETERS, M., MCSHANE, P., GRAY, D. W. R., & MORRIS, P. J. (1986) · Transplantation · doi:10.1097/00007890-198612000-00022 · Cited by 245
Peers, B. (1994) · Molecular Endocrinology · doi:10.1210/me.8.12.1798 · Cited by 224
The Insulin Receptor and Its Cellular Targets1
Kido, Y., Nakae, J., & Accili, D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7306 · Cited by 223
Watada, H., Kajimoto, Y., Umayahara, Y., Matsuoka, T.-A., Kaneto, H., Fujitani, Y., Kamada, T., Kawamori, R., & Yamasaki, Y. (1996) · Diabetes · doi:10.2337/diab.45.11.1478 · Cited by 221
Abstracts of the IDF Congress in Paris 2003
(2003) · Diabetologia · doi:10.1007/s00125-003-1190-9 · Cited by 211
Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor
Xuan, S., Kitamura, T., Nakae, J., Politi, K., Kido, Y., Fisher, P. E., Morroni, M., Cinti, S., White, M. F., Herrera, P. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15276 · Cited by 183
Self-citationPdx1 restores β cell function in Irs2 knockout mice
Kushner, J. A., Ye, J., Schubert, M., Burks, D. J., Dow, M. A., Flint, C. L., Dutta, S., Wright, C. V. E., Montminy, M. R., & White, M. F. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14439 · Cited by 176
Self-citationTherapy of type 2 diabetes mellitus based on the actions of glucagon‐like peptide‐1
Holst, J. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.328 · Cited by 169
Evidence for a circulating islet cell growth factor in insulin-resistant states
Flier, S. N., Kulkarni, R., & Kahn, C. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131192998 · Cited by 158
Self-citationSuppression of β Cell Energy Metabolism and Insulin Release by PGC-1α
Yoon, J. C., Xu, G., Deeney, J. T., Yang, S.-N., Rhee, J., Puigserver, P., Levens, A. R., Yang, R., Zhang, C.-Y., Lowell, B. B., et al. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00170-9 · Cited by 143
Goss, J. A., Schock, A. P., Brunicardi, F. C., Goodpastor, S. E., Garber, A. J., Soltes, G. D., Barth, M. H., Froud, T., Alejandro, R., & Ricordi, C. (2002) · Transplantation · doi:10.1097/00007890-200212270-00020 · Cited by 134
The Insulin Receptor and Its Cellular Targets
Kido, Y. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.972 · Cited by 103
Herold, K. C., Vezys, V., Sun, Q., Viktora, D., Seung, E., Reiner, S. L., & Brown, D. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3521 · Cited by 99
Ehrmann, D. A., Tang, X. A., Yoshiuchi, I., Cox, N. J., & Bell, G. I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020216 · Cited by 99
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia
Reaven, G. M. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1462-8902.2001.00037.x · Cited by 92
Lugari, R., Dei, A., Ugolotti, D., Finardi, L., Barilli, A., Ognibene, C. M., Luciani, A., Zandomeneghi, R., & GNUDI, A. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-23199 · Cited by 85
Insulin‐secreting β‐cells possess specific receptors for interleukin‐1β
Hammonds, P., Beggs, M., Beresford, G., Espinal, J., Clarke, J., & Mertz, R. J. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80645-y · Cited by 60
Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide
Suarez‐Pinzon, W. L., Strynadka, K. D., Schulz, R., & Rabinovitch, A. (1994) · Endocrinology · doi:10.1210/endo.134.3.8119136 · Cited by 59
Human Insulin Receptor Substrate-2 (IRS-2) Is a Primary Progesterone Response Gene
Vaßen, L., Węgrzyn, W., & Klein‐Hitpaß, L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.3.0256 · Cited by 56
Watada, H., Kajimoto, Y., Umayahara, Y., Matsuoka, T., Kaneto, H., Fujitani, Y., Kamada, T., Kawamori, R., & Yamasaki, Y. (1996) · Diabetes · doi:10.2337/diabetes.45.11.1478 · Cited by 56
Ehrmann, D. A., Breda, E., Cavaghan, M. K., Bajramovic, S., Imperial, J., TOFFOLO, G. M., Cobelli, C., & Polonsky, K. S. (2002) · Diabetologia · doi:10.1007/s00125-002-0776-y · Cited by 41
Pdx1 Expression in Irs2-deficient Mouse β-Cells Is Regulated in a Strain-dependent Manner
Suzuki, R., Tobe, K., Terauchi, Y., Komeda, K., Kubota, N., Eto, K., Yamauchi, T., Azuma, K., Kaneto, H., Taguchi, T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307004200 · Cited by 28
Zumsteg, U., Reimers, J. I., Pociot, F., M�rch, L., Helqvist, S., Brendel, M. D., Alejandro, R., Mandrup-Poulsen, T. R., Dinarello, C. A., & Nerup, J. (1993) · Diabetologia · doi:10.1007/bf00401148 · Cited by 26
Human Insulin Receptor Substrate-2 (IRS-2) Is a Primary Progesterone Response Gene
en, L. V. (1999) · Molecular Endocrinology · doi:10.1210/me.13.3.485 · Cited by 14
Avruch, J. (1998) · Nature · doi:10.1038/35998 · Cited by 7
Cited by
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
“In Irs-2 -knockout mice, reintroduction of β-cell IRS-2 alone reversed the diabetic phenotype by increasing β-cell replication, resulting in an increase in β-cell number and mas”
BackgroundType 2 Diabetes-a Matter of ß-Cell Life and Death?
Rhodes, C. J. (2005) · Science · doi:10.1126/science.1104345 · Cited by 896
Insulin signaling in health and disease
White, M. F. (2003) · Science · doi:10.1126/science.1092952 · Cited by 733
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
Current views on type 2 diabetes
Lin, Y., & Sun, Z. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0260 · Cited by 457
Metadata
- Authors
- Hennige, A. M., Burks, D. J., Ozcan, U., Kulkarni, R. N., Ye, J., Park, S., Schubert, M., Fisher, T. L., Dow, M. A., Leshan, R., Zakaria, M., Mossa-Basha, M., & White, M. F.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-11-15
- Volume
- 112
- Issue
- 10
- Pages
- 1521-1532
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2146921827
- Cited by
- 262
- References
- 59
- FWCI
- 16.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.